217 related articles for article (PubMed ID: 11405804)
1. Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n.
Jardim LB; Pereira ML; Silveira I; Ferro A; Sequeiros J; Giugliani R
Arch Neurol; 2001 Jun; 58(6):899-904. PubMed ID: 11405804
[TBL] [Abstract][Full Text] [Related]
2. CAG repeat length and disease duration in Machado-Joseph disease: a new clinical classification.
Maruyama H; Kawakami H; Kohriyama T; Sakai T; Doyu M; Sobue G; Seto M; Tsujihata M; Oh-i T; Nishio T; Sunohara N; Takahashi R; Ohtake T; Hayashi M; Nishimura M; Saida T; Abe K; Itoyama Y; Matsumoto H; Nakamura S
J Neurol Sci; 1997 Nov; 152(2):166-71. PubMed ID: 9415538
[TBL] [Abstract][Full Text] [Related]
3. Muscle excitability abnormalities in Machado-Joseph disease.
França MC; D'Abreu A; Nucci A; Lopes-Cendes I
Arch Neurol; 2008 Apr; 65(4):525-9. PubMed ID: 18413477
[TBL] [Abstract][Full Text] [Related]
4. Machado-Joseph disease.
Sudarsky L; Coutinho P
Clin Neurosci; 1995; 3(1):17-22. PubMed ID: 7614089
[TBL] [Abstract][Full Text] [Related]
5. Analysis of CAG trinucleotide expansion associated with Machado-Joseph disease.
Watanabe M; Abe K; Aoki M; Kameya T; Kaneko J; Shoji M; Ikeda M; Shizuka M; Ikeda Y; Iizuka T; Hirai S; Itoyama Y
J Neurol Sci; 1996 Mar; 136(1-2):101-7. PubMed ID: 8815156
[TBL] [Abstract][Full Text] [Related]
6. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.
Dürr A; Stevanin G; Cancel G; Duyckaerts C; Abbas N; Didierjean O; Chneiweiss H; Benomar A; Lyon-Caen O; Julien J; Serdaru M; Penet C; Agid Y; Brice A
Ann Neurol; 1996 Apr; 39(4):490-9. PubMed ID: 8619527
[TBL] [Abstract][Full Text] [Related]
7. Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation.
Schöls L; Amoiridis G; Epplen JT; Langkafel M; Przuntek H; Riess O
J Neurol Neurosurg Psychiatry; 1996 Nov; 61(5):466-70. PubMed ID: 8937340
[TBL] [Abstract][Full Text] [Related]
8. Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report.
Bettencourt C; Santos C; Coutinho P; Rizzu P; Vasconcelos J; Kay T; Cymbron T; Raposo M; Heutink P; Lima M
BMC Neurol; 2011 Oct; 11():131. PubMed ID: 22023810
[TBL] [Abstract][Full Text] [Related]
9. Searching for modulating effects of SCA2, SCA6 and DRPLA CAG tracts on the Machado-Joseph disease (SCA3) phenotype.
Jardim L; Silveira I; Pereira ML; do Céu Moreira M; Mendonça P; Sequeiros J; Giugliani R
Acta Neurol Scand; 2003 Mar; 107(3):211-4. PubMed ID: 12614315
[TBL] [Abstract][Full Text] [Related]
10. Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients.
Saute JA; Silva AC; Souza GN; Russo AD; Donis KC; Vedolin L; Saraiva-Pereira ML; Portela LV; Jardim LB
Cerebellum; 2012 Sep; 11(3):771-4. PubMed ID: 22090366
[TBL] [Abstract][Full Text] [Related]
11. Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado-Joseph disease.
Onodera O; Idezuka J; Igarashi S; Takiyama Y; Endo K; Takano H; Oyake M; Tanaka H; Inuzuka T; Hayashi T; Yuasa T; Ito J; Miyatake T; Tsuji S
Ann Neurol; 1998 Mar; 43(3):288-96. PubMed ID: 9506544
[TBL] [Abstract][Full Text] [Related]
12. Studies of the CAG repeat in the Machado-Joseph disease gene in Taiwan.
Hsieh M; Tsai HF; Lu TM; Yang CY; Wu HM; Li SY
Hum Genet; 1997 Aug; 100(2):155-62. PubMed ID: 9254842
[TBL] [Abstract][Full Text] [Related]
13. Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease.
Matilla T; McCall A; Subramony SH; Zoghbi HY
Ann Neurol; 1995 Jul; 38(1):68-72. PubMed ID: 7611728
[TBL] [Abstract][Full Text] [Related]
14. Machado-Joseph disease: clinical, molecular, and metabolic characterization in Chinese kindreds.
Soong B; Cheng C; Liu R; Shan D
Ann Neurol; 1997 Apr; 41(4):446-52. PubMed ID: 9124801
[TBL] [Abstract][Full Text] [Related]
15. Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus.
Cancel G; Abbas N; Stevanin G; Dürr A; Chneiweiss H; Néri C; Duyckaerts C; Penet C; Cann HM; Agid Y
Am J Hum Genet; 1995 Oct; 57(4):809-16. PubMed ID: 7573040
[TBL] [Abstract][Full Text] [Related]
16. Caring for Machado-Joseph disease: current understanding and how to help patients.
D'Abreu A; França MC; Paulson HL; Lopes-Cendes I
Parkinsonism Relat Disord; 2010 Jan; 16(1):2-7. PubMed ID: 19811945
[TBL] [Abstract][Full Text] [Related]
17. Sleep apnea in Machado-Joseph disease: a clinical and polysomnographic evaluation.
Folha Santos FA; de Carvalho LBC; Prado LFD; do Prado GF; Barsottini OG; Pedroso JL
Sleep Med; 2018 Aug; 48():23-26. PubMed ID: 29852360
[TBL] [Abstract][Full Text] [Related]
18. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
19. [Molecular genetics of Machado-Joseph disease].
Kawakami H; Maruyama H; Nakamura S
Nihon Rinsho; 1996 Mar; 54(3):854-60. PubMed ID: 8904248
[TBL] [Abstract][Full Text] [Related]
20. Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype.
van Alfen N; Sinke RJ; Zwarts MJ; Gabreëls-Festen A; Praamstra P; Kremer BP; Horstink MW
Ann Neurol; 2001 Jun; 49(6):805-7. PubMed ID: 11409435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
